Storia in 1 fonti

How Kardigan spun deal leftovers into a $400M IPO

CEO Tassos Gianakakos said having late-stage assets and a team fortified at MyoKardia really resonated with investors. SpaceX's huge public offering didn't hurt either.

Raccontata da

biopharmadive.com

Timeline cronologica

martedì 23 giugno 2026·biopharmadive.com
How Kardigan spun deal leftovers into a $400M IPO
CEO Tassos Gianakakos said having late-stage assets and a team fortified at MyoKardia really resonated with investors. SpaceX's huge public offering didn't hurt either.